Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
Ruben AG van Eerden,1 Ron HJ Mathijssen,1 Stijn LW Koolen1,2 1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 2Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, the NetherlandsCorrespondence: Ruben AG van EerdenDepartment of Me...
Guardado en:
Autores principales: | van Eerden RAG, Mathijssen RHJ, Koolen SLW |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da2b094e68184f01a02aca51e7ee3acb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Selenium as a pleiotropic agent for medical discovery and drug delivery
por: Guan BZ, et al.
Publicado: (2018) -
Recent advances in "smart" delivery systems for extended drug release in cancer therapy
por: Kalaydina RV, et al.
Publicado: (2018) -
A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery
por: Yang CL, et al.
Publicado: (2018) -
Magnetic nanoparticle hyperthermia potentiates paclitaxel activity in sensitive and resistant breast cancer cells
por: Rivera-Rodriguez A, et al.
Publicado: (2018) -
Recent advances in ultrasound-based transdermal drug delivery
por: Seah BC, et al.
Publicado: (2018)